Your browser doesn't support javascript.
loading
First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient.
Pollack, Seth M; Lu, Hailing; Gnjatic, Sacha; Somaiah, Neeta; O'Malley, Ryan B; Jones, Robin L; Hsu, Frank J; Ter Meulen, Jan.
Afiliação
  • Pollack SM; *Clinical Research Division, Fred Hutchinson Cancer Research Center Department of †Medicine ¶Radiology, University of Washington, Seattle, WA ‡Immune Design, Seattle, WA, and South San Francisco, CA §Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY ∥MD Anderson Cancer Center, Houston, TX #Royal Marsden Hospital/Institute of Cancer Research, London, England.
J Immunother ; 40(8): 302-306, 2017 10.
Article em En | MEDLINE | ID: mdl-28891906

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Imunoterapia Adotiva / Sarcoma Sinovial / Linfócitos T CD8-Positivos / Vacinas Anticâncer / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Imunoterapia Adotiva / Sarcoma Sinovial / Linfócitos T CD8-Positivos / Vacinas Anticâncer / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article